The complete Guidelines for Manufacturers on Application Fees for the CADTH pan-Canadian Oncology Drug Review are now posted on the CADTH website, along with a list of frequently asked questions that provide guidance on the new fee structure. CADTH would like to thank all stakeholders who provided comments during our consultation period.

For more details, go to: https://www.cadth.ca/sites/default/files/pcodr/Communications/pcodr_communication_40.pdf